R. Glynne-jones, P. Nilsson, C. Aschele, V. Goh, D. Peiffert et al., Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up, European Journal of Surgical Oncology (EJSO), vol.40, issue.10, pp.1165-1176, 2014.
DOI : 10.1016/j.ejso.2014.07.030
URL : https://academic.oup.com/annonc/article-pdf/25/suppl_3/iii10/6674996/mdu159.pdf

D. Forman, C. De-martel, C. Lacey, I. Soerjomataram, J. Lortet-tieulent et al., Global Burden of Human Papillomavirus and Related Diseases, Vaccine, vol.30, pp.12-23, 2012.
DOI : 10.1016/j.vaccine.2012.07.055

C. Piketty, H. Selinger-leneman, A. Bouvier, A. Belot, M. Mary-krause et al., Incidence of HIV-Related Anal Cancer Remains Increased Despite Long-Term Combined Antiretroviral Treatment: Results From the French Hospital Database on HIV, Journal of Clinical Oncology, vol.30, issue.35, pp.4360-4366, 2012.
DOI : 10.1200/JCO.2012.44.5486

I. Baricevic, X. He, B. Chakrabarty, A. Oliver, C. Bailey et al., High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: Different implications for vaccine prevention and prognosis, European Journal of Cancer, vol.51, issue.6, pp.776-785, 2015.
DOI : 10.1016/j.ejca.2015.01.058

R. James, R. Glynne-jones, H. Meadows, D. Cunningham, A. Myint et al., Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2??2 factorial trial, The Lancet Oncology, vol.14, issue.6, pp.516-524, 2013.
DOI : 10.1016/S1470-2045(13)70086-X

J. Lefevre, H. Corte, E. Tiret, D. Boccara, M. Chaouat et al., Abdominoperineal Resection for Squamous Cell Anal Carcinoma: Survival and Risk Factors for Recurrence, Annals of Surgical Oncology, vol.29, issue.13, pp.4186-4192, 2012.
DOI : 10.1016/S0021-7697(08)74312-6

P. Mariani, A. Ghanneme, A. De-la-rochefordiere, J. Girodet, M. Falcou et al., Abdominoperineal Resection for Anal Cancer, Diseases of the Colon & Rectum, vol.51, issue.10, pp.1495-1501, 2008.
DOI : 10.1007/s10350-008-9361-x

G. Dotto and A. Rustgi, Squamous Cell Cancers: A Unified Perspective on Biology and Genetics, Cancer Cell, vol.29, issue.5, pp.622-637, 2016.
DOI : 10.1016/j.ccell.2016.04.004

M. Bernardi, S. Ngan, M. Michael, A. Lynch, A. Heriot et al., Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention, The Lancet Oncology, vol.16, issue.16, pp.611-621, 2015.
DOI : 10.1016/S1470-2045(15)00292-2

W. Cacheux, E. Rouleau, A. Briaux, P. Tsantoulis, P. Mariani et al., Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection, British Journal of Cancer, vol.513, issue.12, pp.1387-1394, 2016.
DOI : 10.1016/j.cell.2015.08.015
URL : https://hal.archives-ouvertes.fr/hal-01478384

C. Gardini, A. Capelli, L. Ulivi, P. Giannini, M. Freier et al., KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC), KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC), p.92071, 2014.
DOI : 10.1371/journal.pone.0092071.t004

J. Chung, E. Sanford, A. Johnson, S. Klempner, A. Schrock et al., Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes, Annals of Oncology, vol.29, issue.(4), pp.1336-1341, 2016.
DOI : 10.1200/JCO.2009.24.6116

B. Smaglo, A. Tesfaye, T. Halfdanarson, J. Meyer, J. Wang et al., Comprehensive multiplatform biomarker analysis of 199

V. Morris, X. Rao, C. Pickering, W. Foo, A. Rashid et al., Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal, Molecular Cancer Research, vol.15, issue.11, 2017.
DOI : 10.1158/1541-7786.MCR-17-0060

S. Forbes, D. Beare, H. Boutselakis, S. Bamford, N. Bindal et al., COSMIC: somatic cancer genetics at high-resolution, Nucleic Acids Research, vol.166, issue.D1, pp.777-783, 2017.
DOI : 10.1016/j.cell.2016.06.017
URL : https://academic.oup.com/nar/article-pdf/45/D1/D777/8846917/gkw1121.pdf

A. Laforest, T. Aparicio, A. Zaanan, F. Silva, A. Didelot et al., ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma, European Journal of Cancer, vol.50, issue.10, pp.1740-1746, 2014.
DOI : 10.1016/j.ejca.2014.04.007

A. Ojesina, L. Lichtenstein, S. Freeman, C. Pedamallu, I. Imaz-rosshandler et al., Landscape of genomic alterations in cervical carcinomas, Nature, vol.27, issue.7488, pp.371-375, 2014.
DOI : 10.1038/ng.2702

L. Morris, A. Kaufman, Y. Gong, D. Ramaswami, L. Walsh et al., Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation, Nature Genetics, vol.8, issue.3, pp.253-261, 2013.
DOI : 10.1093/bioinformatics/btm339

N. Yoo, S. Park, and S. Lee, Frameshift mutations of ubiquitination-related genes HERC2, HERC3, TRIP12, UBE2Q1 and UBE4B in gastric and colorectal carcinomas with microsatellite instability, Pathology, vol.43, issue.7, pp.753-755, 2011.
DOI : 10.1097/PAT.0b013e32834c7e78

D. Meulendijks, N. Tomasoa, L. Dewit, P. Smits, R. Bakker et al., HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53, British Journal of Cancer, vol.136, issue.8, pp.1358-1366, 2015.
DOI : 10.1002/ijc.25825

H. Zur-hausen, Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis, Journal of the National Cancer Institute, vol.92, issue.9, pp.690-698, 2000.
DOI : 10.1093/jnci/92.9.690

M. Thomas, D. Pim, and L. Banks, The role of the E6-p53 interaction in the molecular pathogenesis of HPV, Oncogene, vol.18, issue.53, pp.7690-7700, 1999.
DOI : 10.1016/0042-6822(91)90816-T

Y. Gao, Z. Chen, J. Li, X. Hu, X. Shi et al., Genetic landscape of esophageal squamous cell carcinoma, Nature Genetics, vol.12, issue.10, pp.1097-1102, 2014.
DOI : 10.1177/147323000803600209

C. Pickering, J. Zhou, J. Lee, J. Drummond, S. Peng et al., Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma, Clinical Cancer Research, vol.20, issue.24, pp.6582-6592, 2014.
DOI : 10.1158/1078-0432.CCR-14-1768

M. Collado and M. Serrano, The TRIP from ULF to ARF, Cancer Cell, vol.17, issue.4, pp.317-318, 2010.
DOI : 10.1016/j.ccr.2010.03.015

L. Wang, P. Zhang, D. Molkentine, C. Chen, J. Molkentine et al., TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects, Oncogene, vol.31, issue.6, 2016.
DOI : 10.1158/2159-8290.CD-12-0095

S. Dolly, A. Wagner, J. Bendell, H. Kindler, L. Krug et al., Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors, Clinical Cancer Research, vol.22, issue.12, pp.2874-2884, 2016.
DOI : 10.1158/1078-0432.CCR-15-2225

M. Hou, X. Liu, J. Wheler, A. Naing, D. Hong et al., Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience, Oncotarget, vol.5, issue.22, pp.11168-11179, 2014.
DOI : 10.18632/oncotarget.2584

F. Janku, D. Hong, S. Fu, S. Piha-paul, A. Naing et al., Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors, Cell Reports, vol.6, issue.2, pp.377-387, 2014.
DOI : 10.1016/j.celrep.2013.12.035

A. Snyder, V. Makarov, T. Merghoub, J. Yuan, J. Zaretsky et al., Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma, New England Journal of Medicine, vol.371, issue.23, pp.2189-2199, 2014.
DOI : 10.1056/NEJMoa1406498

V. Morris, M. Salem, H. Nimeiri, S. Iqbal, P. Singh et al., Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study, The Lancet Oncology, vol.18, issue.4, pp.446-453, 2017.
DOI : 10.1016/S1470-2045(17)30104-3

L. Alexandrov, S. Nik-zainal, D. Wedge, S. Aparicio, S. Behjati et al., Signatures of mutational processes in human cancer, Nature, vol.27, issue.7463, pp.415-421, 2013.
DOI : 10.1093/bioinformatics/btr354

S. Henderson, A. Chakravarthy, X. Su, C. Boshoff, and T. Fenton, APOBEC-Mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-Driven Tumor Development, Cell Reports, vol.7, issue.6, pp.1833-1841, 2014.
DOI : 10.1016/j.celrep.2014.05.012
URL : https://doi.org/10.1016/j.celrep.2014.05.012

D. Koboldt, Q. Zhang, D. Larson, D. Shen, M. Mclellan et al., VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing, Genome Research, vol.22, issue.3, pp.568-576, 2012.
DOI : 10.1101/gr.129684.111

K. Wang, M. Li, and H. Hakonarson, ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data, Nucleic Acids Research, vol.8, issue.1, p.164, 2010.
DOI : 10.1038/sj.ejhg.5200406

G. Yeo and C. Burge, Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals, Journal of Computational Biology, vol.11, issue.2-3, pp.377-394, 2004.
DOI : 10.1089/1066527041410418

R. Rosenthal, N. Mcgranahan, J. Herrero, B. Taylor, and C. Swanton, deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution, Genome Biology, vol.21, issue.12, p.31, 2016.
DOI : 10.18637/jss.v021.i12

F. Favero, T. Joshi, A. Marquard, N. Birkbak, M. Krzystanek et al., Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data, Annals of Oncology, vol.26, issue.1, pp.64-70, 2015.
DOI : 10.1038/nature10933
URL : https://academic.oup.com/annonc/article-pdf/26/1/64/19651035/mdu479.pdf

R. Shen and V. Seshan, FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing, Nucleic Acids Research, vol.5, issue.16, p.131, 2016.
DOI : 10.1002/humu.20286
URL : https://academic.oup.com/nar/article-pdf/44/16/e131/17437623/gkw520.pdf

A. Gonzalez-perez, C. Perez-llamas, J. Deu-pons, D. Tamborero, M. Schroeder et al., IntOGen-mutations identifies cancer drivers across tumor types, Nature Methods, vol.486, issue.11, pp.1081-1082, 2013.
DOI : 10.1126/scitranslmed.3003161
URL : http://www.nature.com/nmeth/journal/v10/n11/pdf/nmeth.2642.pdf